174 related articles for article (PubMed ID: 38069322)
1. Generating Bone Marrow Chimeric Mouse Using GPR120 Deficient Mouse for the Study of DHA Inhibitory Effect on Osteoclast Formation and Bone Resorption.
Ma J; Kitaura H; Ohori F; Noguchi T; Marahleh A; Kinjo R; Kanou K; Ren J; Miura M; Narita K; Mizoguchi I
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069322
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid inhibits TNF-α-induced osteoclast formation and orthodontic tooth movement through GPR120.
Ma J; Kitaura H; Ogawa S; Ohori F; Noguchi T; Marahleh A; Nara Y; Pramusita A; Kinjo R; Kanou K; Kishikawa A; Ichimura A; Mizoguchi I
Front Immunol; 2022; 13():929690. PubMed ID: 36741381
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption
Kishikawa A; Kitaura H; Kimura K; Ogawa S; Qi J; Shen WR; Ohori F; Noguchi T; Marahleh A; Nara Y; Ichimura A; Mizoguchi I
Front Endocrinol (Lausanne); 2019; 10():157. PubMed ID: 30949128
[TBL] [Abstract][Full Text] [Related]
4. TNF-α is responsible for the contribution of stromal cells to osteoclast and odontoclast formation during orthodontic tooth movement.
Ogawa S; Kitaura H; Kishikawa A; Qi J; Shen WR; Ohori F; Noguchi T; Marahleh A; Nara Y; Ochi Y; Mizoguchi I
PLoS One; 2019; 14(10):e0223989. PubMed ID: 31618254
[TBL] [Abstract][Full Text] [Related]
5. G Protein-Coupled Receptor 120 Signaling Negatively Regulates Osteoclast Differentiation, Survival, and Function.
Kim HJ; Yoon HJ; Kim BK; Kang WY; Seong SJ; Lim MS; Kim SY; Yoon YR
J Cell Physiol; 2016 Apr; 231(4):844-51. PubMed ID: 26280807
[TBL] [Abstract][Full Text] [Related]
6. GPR120 Inhibits RANKL-Induced Osteoclast Formation and Resorption by Attenuating Reactive Oxygen Species Production in RAW264.7 Murine Macrophages.
Sithole C; Pieterse C; Howard K; Kasonga A
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638884
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
[TBL] [Abstract][Full Text] [Related]
8. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo.
Kitaura H; Sands MS; Aya K; Zhou P; Hirayama T; Uthgenannt B; Wei S; Takeshita S; Novack DV; Silva MJ; Abu-Amer Y; Ross FP; Teitelbaum SL
J Immunol; 2004 Oct; 173(8):4838-46. PubMed ID: 15470024
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
[TBL] [Abstract][Full Text] [Related]
10. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages.
Kitaura H; Nagata N; Fujimura Y; Hotokezaka H; Tatamiya M; Nakao N; Yoshida N; Nakayama K
Immunol Lett; 2003 Sep; 88(3):193-8. PubMed ID: 12941478
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid.
Rahman MM; Bhattacharya A; Fernandes G
J Cell Physiol; 2008 Jan; 214(1):201-9. PubMed ID: 17929247
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
[TBL] [Abstract][Full Text] [Related]
14. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
15. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.
O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF
Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728
[TBL] [Abstract][Full Text] [Related]
16. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
[TBL] [Abstract][Full Text] [Related]
17. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
18. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
19. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
20. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells.
Bai S; Kopan R; Zou W; Hilton MJ; Ong CT; Long F; Ross FP; Teitelbaum SL
J Biol Chem; 2008 Mar; 283(10):6509-18. PubMed ID: 18156632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
